Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
PLSE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.60%319.700.7%$884.44m
TMOThermo Fisher Scientific, Inc. -1.10%625.881.0%$846.65m
ABTAbbott Laboratories 0.78%126.750.8%$677.06m
MDTMedtronic Plc -1.13%105.490.6%$642.36m
ISRGIntuitive Surgical, Inc. -1.36%319.930.8%$443.56m
BDXBecton, Dickinson & Co. 1.94%241.731.0%$387.76m
DXCMDexCom, Inc. -2.53%548.357.8%$372.22m
BSXBoston Scientific Corp. 0.13%38.121.0%$348.18m
SYKStryker Corp. 1.07%239.161.3%$321.89m
ALGNAlign Technology, Inc. -1.51%602.296.4%$293.96m
EWEdwards Lifesciences Corp. 0.15%107.470.4%$258.41m
AAgilent Technologies, Inc. -1.78%148.211.6%$244.58m
ZBHZimmer Biomet Holdings, Inc. 0.14%119.771.7%$226.77m
IDXXIDEXX Laboratories, Inc. -1.42%599.453.8%$224.67m
WSTWest Pharmaceutical Services, Inc. -1.58%435.671.6%$182.80m

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.